<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cysticercosis: Epidemiology, transmission, and prevention</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cysticercosis: Epidemiology, transmission, and prevention</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cysticercosis: Epidemiology, transmission, and prevention</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">A Clinton White, Jr, MD, FACP, FIDSA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cysticercosis is caused by the larval stage of the tapeworm <em>Taenia solium</em>; clinical syndromes include neurocysticercosis and extraneural cysticercosis [<a href="#rid1">1</a>]. In endemic areas, neurocysticercosis is an important cause of adult-onset seizures [<a href="#rid2">2,3</a>].</p><p>The epidemiology and transmission of cysticercosis will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of cysticercosis and the life cycle of <em>T. solium</em> are discussed separately. (See  <a class="medical medical_review" href="/d/html/5678.html" rel="external">"Cysticercosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5681.html" rel="external">"Cysticercosis: Treatment"</a> and  <a class="medical medical_review" href="/d/html/5685.html" rel="external">"Tapeworm infections"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Cysticercosis is endemic in many regions of Central and South America, sub-Saharan Africa, India, and Asia [<a href="#rid4">4-10</a>]. Data on the global prevalence of neurocysticercosis are limited. There are a few population-based studies on prevalence incorporating neuroimaging studies [<a href="#rid10">10-14</a>]. In endemic villages, approximately 10 to 20 percent of individuals have evidence of neurocysticercosis on computed tomography scans, primarily in the form of calcified lesions [<a href="#rid15">15-17</a>]. In countries where cysticercosis is endemic, the prevalence is often higher in rural or periurban areas where pigs are raised and sanitary conditions are suboptimal [<a href="#rid12">12,13</a>]. In some such communities, the rate of epilepsy approaches 3 percent, approximately 30 percent of these cases have evidence of cysticercosis [<a href="#rid12">12-14</a>].</p><p>Individuals with cysticercosis also present for medical attention outside of endemic areas, particularly where there are significant numbers of immigrants [<a href="#rid9">9,18-23</a>]. A review of a national database estimated that there were more than 18,000 hospitalizations for neurocysticercosis in the United States between 2003 and 2012 [<a href="#rid21">21</a>]. The incidence of neurocysticercosis may be twice the estimates based on inpatient data; in a review of an Oregon state database including 125 patients with neurocysticercosis, 56 percent were seen as outpatients only [<a href="#rid24">24</a>]. In a prospective study including 1800 patients with seizures admitted to 11 emergency departments in the United States over a two-year period, neurocysticercosis was the etiologic agent in about 2 percent of cases [<a href="#rid19">19</a>]. Similar data were generated from a retrospective study in Houston [<a href="#rid18">18</a>].</p><p>Individuals with no history of pork consumption or travel to endemic areas can also develop neurocysticercosis. In a report of four cases in an Orthodox Jewish community (whose dietary laws strictly prohibit pork consumption), infection was transmitted by domestic workers from Latin American countries where <em>T. solium</em> is endemic [<a href="#rid25">25</a>]. Similarly, cases in Kuwait (a nonendemic country) have also been linked to tapeworm carriers from endemic regions [<a href="#rid23">23</a>]. Epidemiologic studies have demonstrated tight clustering in households; household contacts of patients with neurocysticercosis have a threefold higher risk of positive serology for cysticercosis compared with controls [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H3"><span class="h1">LIFE CYCLE AND TRANSMISSION</span><span class="headingEndMark"> — </span>Cysticercosis is transmitted by ingestion of <em>T. solium</em> eggs shed in the stool of a human tapeworm carrier  (<a class="graphic graphic_figure graphicRef75531" href="/d/graphic/75531.html" rel="external">figure 1</a>) [<a href="#rid5">5,6</a>]. Pigs acquire infection through ingestion of proglottids, infected human feces, or food contaminated by infected human feces. Rates of transmission are high in rural communities where pigs roam free and human fecal contamination of soil is common. </p><p>Following ingestion, embryos (oncospheres) hatch in the small intestine, invade the bowel wall, and disseminate hematogenously to brain, striated muscles, liver, and/or other tissues. Over a period of three to eight weeks, tissue cysticerci develop; these consist of membranous walls filled with fluid and an invaginated scolex. </p><p>Humans develop <em>T. solium</em> tapeworms after ingesting undercooked pork containing cysticerci in muscle tissue [<a href="#rid5">5,6</a>]. Once ingested, the scolex evaginates and attaches to the human small intestine by its suckers and hooks. Proglottids (segments) arise from the base of the scolex, gradually enlarge and are displaced from the neck by new proglottids. The proglottids mature over a period of two to four months. Adult tapeworms can reside in the small intestine for years; they may develop up to 7 m in length with each proglottid segment containing 50,000 to 100,000 eggs. The proglottids or eggs are infectious for pigs.</p><p>Humans can also be infected by ingestion of the ova from a tapeworm carrier. After ingestion, the ova hatch and larvae are distributed via the blood stream to a variety of tissues. Cysts located in the brain result in neurocysticercosis; humans with cysticercosis are incidental dead-end hosts. For immigrants from an endemic to a nonendemic area, the median period between immigration and symptom onset is 3.5 years [<a href="#rid18">18,27</a>].</p><p>A common misconception is that cysticercosis is acquired directly by eating pork. However, as the life cycle illustrates, ingestion of infected pork only causes adult tapeworm infestation (taeniasis); infected pork contains the larval cysts that develop into adult worms in the human intestine, but does not contain the eggs that cause cysticercosis  (<a class="graphic graphic_figure graphicRef75531" href="/d/graphic/75531.html" rel="external">figure 1</a>). Some patients with cysticercosis are tapeworm carriers, but most individuals with intestinal tapeworm infection do not develop symptomatic cysticercosis [<a href="#rid26">26</a>]. However, human tapeworm carriers are at risk for fecal-oral autoinoculation of eggs and subsequent development of cysticercosis.</p><p>Transmission of cysticercosis was previously thought to occur by indirect means, such as by the ingestion of produce irrigated with water contaminated with human feces containing <em>T. solium</em> eggs. However, epidemiologic evidence suggests that the most common source of infective eggs is an asymptomatic household tapeworm carrier [<a href="#rid5">5,6,26</a>]. Therefore, cysticercosis should be viewed as a disease largely transmitted from person to person, with infected pigs as perpetuators of infection.</p><p>The <em>Taenia </em>life cycle is discussed in further detail separately. (See  <a class="medical medical_review" href="/d/html/5685.html" rel="external">"Tapeworm infections", section on 'Taeniasis'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>There are several stages of transmission that can be targeted, and eradication programs likely require implementation of all of these strategies [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Tapeworms in humans</span><span class="headingEndMark"> — </span>Preventing human tapeworm infection is important for reducing the reservoir of egg carriers and can be done by eliminating human consumption of pork contaminated with viable cysticerci. Methods include:</p><p class="bulletIndent1"><span class="glyph">●</span>Inspection of pork for cysticerci, which are visible in raw meat ("measly meat"). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Freezing or adequately cooking meat to destroy cysticerci; pickling and salting are not adequate techniques. These methods have been successful in countries with appropriate resources but not in resource-limited settings in which inspection can be bypassed.</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Cysticercosis in pigs</span><span class="headingEndMark"> — </span>Preventing the transmission of cysticercal infections to pigs can be accomplished by eliminating access of pigs to human fecal material. Methods include improving sanitary conditions for proper disposal of human waste (using latrines or sewage systems) and confining pigs so they are not allowed to roam freely in areas with human waste [<a href="#rid28">28</a>]. However, cost and local taboos are barriers to improving sanitation in the poorest areas [<a href="#rid29">29,30</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Reducing transmission</span><span class="headingEndMark"> — </span>Mechanisms for interrupting the transmission of eggs between humans include:</p><p class="bulletIndent1"><span class="glyph">●</span>Community education regarding routes of transmission</p><p class="bulletIndent1"><span class="glyph">●</span>Good personal hygiene and hand washing prior to food preparation</p><p class="bulletIndent1"><span class="glyph">●</span>Targeted treatment for human tapeworm carriers (perhaps identified by history of proglottid passage)</p><p class="bulletIndent1"><span class="glyph">●</span>Mass community anthelminthic programs to treat tapeworm carriers</p><p></p><p>The treatments of choice for mass chemotherapy of <em>T. solium </em>tapeworms are niclosamide or <a class="drug drug_general" data-topicid="9805" href="/d/drug information/9805.html" rel="external">praziquantel</a> [<a href="#rid31">31</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Niclosamide dosing for adults consists of 2 g (single dose; four chewable tablets); dosing for children &gt;34 kg consists of 1.5 g and dosing for children 11 and 34 kg consists of 1 g. Niclosamide is no longer marketed in the United States. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9805" href="/d/drug information/9805.html" rel="external">Praziquantel</a> dosing consists of 10 mg/kg. There is a low risk of seizures in patients with occult neurocysticercosis who are treated with praziquantel; this may be mitigated by screening [<a href="#rid31">31,32</a>]. </p><p></p><p class="headingAnchor" id="H8"><span class="h2">Vaccination</span><span class="headingEndMark"> — </span>No vaccine has been studied in humans. </p><p>A recombinant vaccine has proven highly effective in preventing porcine cysticercosis and is licensed in India. Vaccination has proved critical in programs to eliminate cysticercosis in Peru, Zambia, and Laos [<a href="#rid32">32-34</a>]. Since pigs may be infected before they can respond to the vaccine, vaccine is usually combined with treatment for pre-existing infection (usually with oxfendazole).</p><p>Mathematical models suggest that eradication of <em>T. solium</em> may be best achieved by a combination of pig vaccination, mass chemotherapy for pigs, and mass chemotherapy for human tapeworm carriers [<a href="#rid6">6,35</a>], which have been confirmed in field studies from South America, Africa, and Asia [<a href="#rid32">32-34</a>]. However, efforts focused around pigs may be as effective as untargeted approaches [<a href="#rid36">36</a>]. </p><p class="headingAnchor" id="H494141324"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/127187.html" rel="external">"Society guideline links: Cysticercosis"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Cysticercosis is caused by the larval stage of the tapeworm <em>Taenia solium</em>. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cysticercosis is endemic in many regions of Central and South America, sub-Saharan Africa, India, and Asia. Among patients with seizures in endemic areas, it is estimated that approximately 30 percent of patients have cysticercosis infection. The prevalence of cysticercosis varies and is often higher in rural or periurban areas, especially where pigs are raised and where sanitary conditions are suboptimal. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The most common source of infective eggs is an asymptomatic household tapeworm carrier. Household contacts of patients with neurocysticercosis have a threefold higher risk of positive serology for cysticercosis in comparison with controls. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cysticercosis is transmitted by ingestion of <em>T. solium</em> eggs shed in the stool of a human tapeworm carrier. Following ingestion, embryos (oncospheres) hatch in the small intestine, invade the bowel wall, and disseminate hematogenously to brain, muscles, and/or other tissues. (See <a class="local">'Life cycle and transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Humans become <em>T. solium</em> tapeworm carriers by ingesting undercooked pork containing cysticerci in muscle tissue. A small minority of patients with cysticercosis are tapeworm carriers, and most individuals with intestinal tapeworm infection do not develop symptomatic cysticercosis. (See <a class="local">'Life cycle and transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A common misconception is that one can acquire neurocysticercosis directly by eating pork. However, ingestion of infected pork causes adult tapeworm infestation (taeniasis) but not cysticercosis. This is because infected pork contains the larval cysts that develop into adult worms in human intestine but does not contain the eggs that cause cysticercosis. (See <a class="local">'Life cycle and transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eradication programs will likely require implementation of strategies to reduce transmission at several stages. In endemic countries, the main tools include vaccination and mass treatment to eliminate human tapeworms. Other measures include preventing human tapeworm infection due to pork consumption, improving sanitary conditions to prevent transmission of cysticercal infections from humans to pigs, and measures to interrupt transmission of eggs between humans. (See <a class="local">'Prevention'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 2018; 66:e49.</a></li><li><a class="nounderline abstract_t">Ndimubanzi PC, Carabin H, Budke CM, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 2010; 4:e870.</a></li><li><a class="nounderline abstract_t">Debacq G, Moyano LM, Garcia HH, et al. Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS Negl Trop Dis 2017; 11:e0005153.</a></li><li class="breakAll">World Health Organization. WHO guidelines on management of Taenia solium neurocysticercosis. https://www.who.int/publications/i/item/9789240032231 (Accessed on November 03, 2021).</li><li><a class="nounderline abstract_t">Garcia HH, Gonzalez AE, Gilman RH. Taenia solium Cysticercosis and Its Impact in Neurological Disease. Clin Microbiol Rev 2020; 33.</a></li><li><a class="nounderline abstract_t">Dixon MA, Winskill P, Harrison WE, Basáñez MG. Taenia solium taeniasis/cysticercosis: From parasite biology and immunology to diagnosis and control. Adv Parasitol 2021; 112:133.</a></li><li><a class="nounderline abstract_t">Zulu G, Stelzle D, Mwape KE, et al. The epidemiology of human Taenia solium infections: A systematic review of the distribution in Eastern and Southern Africa. PLoS Negl Trop Dis 2023; 17:e0011042.</a></li><li><a class="nounderline abstract_t">Xie Y, Shi D, Wang X, et al. Prevalence trend and burden of neglected parasitic diseases in China from 1990 to 2019: findings from global burden of disease study. Front Public Health 2023; 11:1077723.</a></li><li><a class="nounderline abstract_t">Stelzle D, Abraham A, Kaminski M, et al. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. J Travel Med 2023; 30.</a></li><li><a class="nounderline abstract_t">Stelzle D, Schmidt V, Keller L, et al. Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries-A pooled analysis. PLoS Negl Trop Dis 2022; 16:e0010870.</a></li><li><a class="nounderline abstract_t">Winkler AS. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health 2012; 106:261.</a></li><li><a class="nounderline abstract_t">Rajshekhar V, Raghava MV, Prabhakaran V, et al. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 2006; 67:2135.</a></li><li><a class="nounderline abstract_t">Moyano LM, Saito M, Montano SM, et al. Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru. PLoS Negl Trop Dis 2014; 8:e2692.</a></li><li><a class="nounderline abstract_t">Del Brutto OH, Recalde BY, Mera RM. Incidence of Adult-Onset Epilepsy and the Contributory Role of Neurocysticercosis in a Five-Year, Population-Based, Prospective Study in Rural Ecuador. Am J Trop Med Hyg 2021; 106:208.</a></li><li><a class="nounderline abstract_t">Prasad KN, Verma A, Srivastava S, et al. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India. Trans R Soc Trop Med Hyg 2011; 105:531.</a></li><li><a class="nounderline abstract_t">Fleury A, Gomez T, Alvarez I, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 2003; 22:139.</a></li><li><a class="nounderline abstract_t">Moyano LM, O'Neal SE, Ayvar V, et al. High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru. PLoS Negl Trop Dis 2016; 10:e0005130.</a></li><li><a class="nounderline abstract_t">del la Garza Y, Graviss EA, Daver NG, et al. Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg 2005; 73:766.</a></li><li><a class="nounderline abstract_t">Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002; 8:608.</a></li><li><a class="nounderline abstract_t">Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerg Infect Dis 2007; 13:230.</a></li><li><a class="nounderline abstract_t">O'Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012. Emerg Infect Dis 2015; 21:969.</a></li><li><a class="nounderline abstract_t">Croker C, Redelings M, Reporter R, et al. The impact of neurocysticercosis in california: a review of hospitalized cases. PLoS Negl Trop Dis 2012; 6:e1480.</a></li><li><a class="nounderline abstract_t">Iqbal J, Ahmad S, Al-Awadhi M, et al. A Large Case Series of Neurocysticercosis in Kuwait, a Nonendemic Arabian Gulf Country in the Middle East Region. Microorganisms 2021; 9.</a></li><li><a class="nounderline abstract_t">Flecker RH, O'Neal SE, Townes JM. Evaluating Healthcare Claims for Neurocysticercosis by Using All-Payer All-Claims Data, Oregon, 2010-2013. Emerg Infect Dis 2016; 22:2168.</a></li><li><a class="nounderline abstract_t">Schantz PM, Moore AC, Muñoz JL, et al. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 1992; 327:692.</a></li><li><a class="nounderline abstract_t">Lescano AG, Garcia HH, Gilman RH, et al. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis 2009; 3:e371.</a></li><li><a class="nounderline abstract_t">Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 2011; 17:1.</a></li><li><a class="nounderline abstract_t">Gonzales-Gustavson E, Pray IW, Gamboa R, et al. Evaluating the Role of Corrals and Insects in the Transmission of Porcine Cysticercosis: A Cohort Study. Pathogens 2023; 12.</a></li><li><a class="nounderline abstract_t">Thys S, Mwape KE, Lefèvre P, et al. Why pigs are free-roaming: Communities' perceptions, knowledge and practices regarding pig management and taeniosis/cysticercosis in a Taenia solium endemic rural area in Eastern Zambia. Vet Parasitol 2016; 225:33.</a></li><li><a class="nounderline abstract_t">Thys S, Mwape KE, Lefèvre P, et al. Why latrines are not used: communities' perceptions and practices regarding latrines in a Taenia solium endemic rural area in Eastern Zambia. PLoS Negl Trop Dis 2015; 9:e0003570.</a></li><li class="breakAll">Pan American Health Organization. Guideline for Preventive Chemotherapy for the Control of Taenia solium Taeniasis. https://www.paho.org/en/documents/guideline-preventive-chemotherapy-control-taenia-solium-taeniasis (Accessed on November 09, 2021).</li><li><a class="nounderline abstract_t">Gabriël S, Mwape KE, Hobbs EC, et al. Evidence for potential elimination of active Taenia solium transmission in Africa? N Engl J Med 2020; 383:396.</a></li><li><a class="nounderline abstract_t">Garcia HH, Gonzalez AE, Tsang VC, et al. Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med 2016; 374:2335.</a></li><li><a class="nounderline abstract_t">Okello AL, Thomas L, Inthavong P, et al. Reprint of "Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR". Acta Trop 2017; 165:261.</a></li><li><a class="nounderline abstract_t">CystiTeam Group for Epidemiology and Modelling of Taenia solium Taeniasis/Cysticercosis. The World Health Organization 2030 goals for Taenia solium: Insights and perspectives from transmission dynamics modelling: CystiTeam Group for Epidemiology and Modelling of Taenia solium Taeniasis/Cysticercosis. Gates Open Res 2019; 3:1546.</a></li><li><a class="nounderline abstract_t">O'Neal SE, Pray IW, Vilchez P, et al. Geographically Targeted Interventions versus Mass Drug Administration to Control Taenia solium Cysticercosis, Peru. Emerg Infect Dis 2021; 27:2389.</a></li></ol></div><div id="topicVersionRevision">Topic 5693 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29481580" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21072231" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28267746" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28267746" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32461308" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Taenia solium Cysticercosis and Its Impact in Neurological Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34024358" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Taenia solium taeniasis/cysticercosis: From parasite biology and immunology to diagnosis and control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37000841" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The epidemiology of human Taenia solium infections: A systematic review of the distribution in Eastern and Southern Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37293619" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevalence trend and burden of neglected parasitic diseases in China from 1990 to 2019: findings from global burden of disease study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36222148" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36342903" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries-A pooled analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23265550" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17190933" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24551255" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34634771" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Incidence of Adult-Onset Epilepsy and the Contributory Role of Neurocysticercosis in a Five-Year, Population-Based, Prospective Study in Rural Ecuador.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21764415" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629280" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : High prevalence of calcified silent neurocysticercosis in a rural village of Mexico.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27992429" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16222023" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Epidemiology of neurocysticercosis in Houston, Texas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12023918" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17479884" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Deaths from cysticercosis, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25988221" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22292097" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The impact of neurocysticercosis in california: a review of hospitalized cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34199952" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A Large Case Series of Neurocysticercosis in Kuwait, a Nonendemic Arabian Gulf Country in the Middle East Region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27869593" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Evaluating Healthcare Claims for Neurocysticercosis by Using All-Payer All-Claims Data, Oregon, 2010-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1495521" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Neurocysticercosis in an Orthodox Jewish community in New York City.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19172178" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21192847" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Public health implications of cysticercosis acquired in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37111483" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Evaluating the Role of Corrals and Insects in the Transmission of Porcine Cysticercosis: A Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27369573" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Why pigs are free-roaming: Communities' perceptions, knowledge and practices regarding pig management and taeniosis/cysticercosis in a Taenia solium endemic rural area in Eastern Zambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25739017" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Why latrines are not used: communities' perceptions and practices regarding latrines in a Taenia solium endemic rural area in Eastern Zambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25739017" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Why latrines are not used: communities' perceptions and practices regarding latrines in a Taenia solium endemic rural area in Eastern Zambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32699455" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Evidence for potential elimination of active Taenia solium transmission in Africa?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27305193" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Elimination of Taenia solium Transmission in Northern Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27887694" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Reprint of "Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31701092" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The World Health Organization 2030 goals for Taenia solium: Insights and perspectives from transmission dynamics modelling: CystiTeam Group for Epidemiology and Modelling of Taenia solium Taeniasis/Cysticercosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34424165" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Geographically Targeted Interventions versus Mass Drug Administration to Control Taenia solium Cysticercosis, Peru.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
